Owen C A, Campbell M A, Boukedes S S, Campbell E J
Department of Medicine, University of Utah Health Sciences Center, Salt Lake City 84132, USA.
J Immunol. 1995 Dec 15;155(12):5803-10.
Catalytically active cathepsin G that is bound to the cell surface of human neutrophils may play a variety of roles in normal neutrophil biology and in pathobiology associated with inflammation. In this study, we describe expression of neutrophil cell surface-bound cathepsin G in response to TNF-alpha and platelet-activating factor (PAF) under conditions in which minimal free release of cathepsin G is detected. TNF-alpha and PAF alone induced modest (two- to threefold) increases in cell surface-bound cathepsin G, but exhibited a marked dose- and time-dependent priming effect for subsequent chemoattractant-induced responses (up to 15- to 25-fold increases in cell surface expression). When optimally primed (TNF-alpha, 100 U/ml, or PAF, 10(-9) M), neutrophils expressed five- to sixfold more cell surface-bound cathepsin G, in comparison with cells exposed to FMLP alone. Priming responses were more rapid with PAF (15 s to 5 min) than with TNF-alpha (1 to 60 min). Optimally primed and FMLP-stimulated neutrophils express approximately 160 ng of catalytically active cathepsin G per 10(6) cells, which represents approximately 11% of the cellular content of unstimulated cells. Cathepsin G binds to the cell surface by a charge-dependent mechanism since: 1) incubation of cells with highly positively charged molecules abrogated agonist-induced up-regulation of the cell surface expression of cathepsin G and 2) cathepsin G was eluted from the cell surface by high concentrations of NaCl. These data indicate that interactions between biologically relevant pro-inflammatory cytokines and chemoattractants serve to markedly up-regulate cell surface-bound cathepsin G. The focused catalytic activity of cell surface-bound cathepsin G may alter endothelial and epithelial barriers, promote thrombogenesis, injure extracellular matrix, and/or facilitate directed migration of neutrophils during inflammation.
与人类中性粒细胞细胞表面结合的具有催化活性的组织蛋白酶G可能在正常中性粒细胞生物学以及与炎症相关的病理生物学中发挥多种作用。在本研究中,我们描述了在检测到组织蛋白酶G极少自由释放的条件下,中性粒细胞细胞表面结合的组织蛋白酶G对肿瘤坏死因子-α(TNF-α)和血小板活化因子(PAF)的反应性表达。单独的TNF-α和PAF仅诱导细胞表面结合的组织蛋白酶G适度增加(两到三倍),但对随后趋化因子诱导的反应表现出显著的剂量和时间依赖性启动效应(细胞表面表达增加高达15到25倍)。当最佳启动时(TNF-α,100 U/ml,或PAF,10⁻⁹ M),与仅暴露于甲酰甲硫氨酰-亮氨酰-苯丙氨酸(FMLP)的细胞相比,中性粒细胞表达的细胞表面结合的组织蛋白酶G多五到六倍。PAF引发反应(15秒至5分钟)比TNF-α(1至60分钟)更快。最佳启动并经FMLP刺激的中性粒细胞每10⁶个细胞表达约160 ng具有催化活性的组织蛋白酶G,这约占未刺激细胞细胞含量的11%。组织蛋白酶G通过电荷依赖性机制结合到细胞表面,因为:1)用高度带正电荷的分子孵育细胞消除了激动剂诱导的组织蛋白酶G细胞表面表达上调,以及2)组织蛋白酶G通过高浓度氯化钠从细胞表面洗脱。这些数据表明,生物学上相关的促炎细胞因子和趋化因子之间的相互作用可显著上调细胞表面结合的组织蛋白酶G。细胞表面结合的组织蛋白酶G的集中催化活性可能会改变内皮和上皮屏障、促进血栓形成、损伤细胞外基质和/或在炎症期间促进中性粒细胞的定向迁移。